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Pasteurella multocida toxin (PMT) is a mitogenic protein
toxin that modulates mammalian signalling cascades. In
pigs, PMT causes atrophic rhinitis characterized by loss of
nasal turbinates. Experimental nasal infection leads to
excess proliferation of bladder epithelial cells suggesting it
has carcinogenic properties. Recently we showed that PMT
induces signal transducers and activators of transcription
(STAT) activity through Gαq mediated activation of JAK
kinases. Activation of the JAK-STAT pathway is persistent,
as PMT does not induce expression of suppressor of
cytokine signalling (SOCS) proteins.
We overexpressed SOCS-1 in HEK293 cells to investigate
if this would downregulate PMT-induced STAT activation.
However, STAT activity was not abrogated; instead, SOCS-
1 enhanced STAT3 activity significantly. To test if this
effect was specific for SOCS-1, we expressed SOCS-1, -3 or
CIS and monitored STAT3 transcriptional activity. Hyper-
activation of STAT3 correlated with the nuclear localiza-
tion of the SOCS protein and SOCS-1 was a much
stronger activator than SOCS-3, while CIS did not
enhance STAT activity. However, a CIS mutant containing
the SOCS-1 nuclear localisation sequence (NLS) acted as
potently as SOCS-1. We next determined the phosphor-
ylation status and expression of the STAT3 activating tyro-
sine kinase JAK2. Interestingly, JAK2 expression levels
were increased in the presence of SOCS-1 eventually lead-
ing to hyperphosphorylation of JAK2. It is known that
SOCS proteins act as E3 ubiquitin ligases that target pro-
teins, for example JAK kinases, to proteasomal degrada-
tion. Oncogenic kinases such as Bcr-Abl can overcome this
process through activation of pathways that lead to serine
phosphorylation of SOCS-1. It is believed that Pim serine/
threonine kinases are crucial for this. Pim kinases are STAT
dependent genes and the protein was shown to interact
with SOCS-1 directly. Cells stimulated with PMT showed
high Pim-1 expression that increased with time and were
strongest after over-night stimulation, while IL6-stimu-
lated cells downregulated Pim-1 expression within 3
hours. Incubation with a Pim-1 specific inhibitor reversed
the SOCS-1-dependent transcriptional hyperactivity of
STAT3 to a great extent. In addition, we found that SOCS-
1 is heavily threonine phosphorylated after PMT-stimula-
tion but not after stimulation with IL-6. We hypothesise
that persistent expression of Pim-1 leads to phosphoryla-
tion of SOCS-1, which protects JAK2 from proteasomal
degradation. JAK2 accumulates, leading to hyperactiva-
tion of STAT3 and probably enhanced transforming
potential. In a colony formation assay using HEK293 cells
PMT was able to induce anchorage independent cell
growth. This effect was even more pronounced in the pres-
ence of SOCS-1. In summary, we show that PMT is able to
hijack signalling cascades much in the same way than
oncogenic tyrosine kinases and that its capacity to trans-
form cells is enhanced by SOCS-1.
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